High expression of CD229 was found in nodal marginal-zone lymphoma (NMZL) (82%), mucosa-associated lymphoid tissue lymphoma (MALT) (86%), and splenic marginal-zone lymphoma (SMZL) (87%) (Table 1 and Figure 4). The gene discussed is LY9; the disease is MALT lymphoma.